abiliti® Closed-Loop Gastric Electrical Stimulation System for Treatment of Obesity: Clinical Results with a 27-Month Follow-Up

Obesity Surgery

Volumn 25, Issue 10, 2015, Pages 1779-1787

  Horbach, T ^a   Thalheimer, A ^b   Seyfried, F ^c   Eschenbacher, F ^a   Schuhmann, P ^d   Meyer, G ^d  

^a Center for Spinal Surgery   (Germany)

^b Neurologische Klinik Bad Aibling   (Germany)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d Wolfart Clinic   (Germany)

Author keywords

Gastric electrical stimulation; Implantable stimulation electrodes; Obesity; Weight loss

Indexed keywords

ANTIINFECTIVE AGENT;

ABDOMINAL PAIN; ACCELEROMETER; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BODY MASS; BROKEN STIMULATION LEAD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLOSED LOOP GASTRIC ELECTRICAL STIMULATION SYSTEM; COGNITION; DEVICE INFECTION; DEVICE SAFETY; DIGESTIVE THERAPEUTIC DEVICE; DISINHIBITION; ELECTRODE IMPLANTATION; ENDOSCOPY; EXERCISE; FEEDING BEHAVIOR; FEMALE; FOLLOW UP; FOOD INTAKE; HEALTH BEHAVIOR; HUMAN; HUNGER; INHIBITION (PSYCHOLOGY); LIFESTYLE MODIFICATION; MALE; MEDICAL DEVICE COMPLICATION; MULTICENTER STUDY; OBESITY; OBSERVATIONAL STUDY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; RECURRENT SUBCUTANEOUS POCKET SEROMA; SENSOR; THREE-FACTOR-EATING-QUESTIONNAIRE; TRANSGASTRIC SENSOR; WEIGHT REDUCTION; CLINICAL TRIAL; DEVICES; ELECTRODE IMPLANT; ELECTROTHERAPY; LIFESTYLE; MIDDLE AGED; OBESITY, MORBID; PHYSIOLOGY; PROSTHESES AND ORTHOSES; QUESTIONNAIRE; STOMACH; TREATMENT OUTCOME;

ADULT; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; EXERCISE; FEEDING BEHAVIOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; HUNGER; LIFE STYLE; MALE; MIDDLE AGED; OBESITY, MORBID; PROSTHESES AND IMPLANTS; QUALITY OF LIFE; STOMACH; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84940959368     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-015-1620-z     Document Type: Article

References (35)

1. Pi-Sunyer FX, Aronne LJ, Heshmati HM, et al. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA J Am Med Assoc. 2006;295(7):761–75.
2. O'Brien PE, Sawyer SM, Laurie C, et al. Laparoscopic adjustable gastric banding in severely obese adolescents: a randomized trial. JAMA J Am Med Assoc. 2010;303(6):519–26.
3. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.
4. Franz MJ, VanWormer JJ, Crain AL, et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc. 2007;107(10):1755–67.
5. Colucci RA. Bariatric surgery in patients with type 2 diabetes: a viable option. Postgrad Med. 2011;123(1):24–33.
6. O'Brien PE. Bariatric surgery: mechanisms, indications and outcomes. J Gastroenterol Hepatol. 2010;25(8):1358–65.
7. D'Argent J. Gastric electrical stimulation as therapy of morbid obesity: preliminary results from the French study. Obes Surg. 2002;12 Suppl 1:21S–5.
8. De Luca M, Segato G, Busetto L, et al. Progress in implantable gastric stimulation: summary of results of the European multi-center study. Obes Surg. 2004;14 Suppl 1:S33–9.
9. Miller K, Hoeller E, Aigner F. The implantable gastric stimulator for obesity: an update of the European Experience in the LOSS (Laparoscopic Obesity Stimulation Survey) Study. Treat Endocrinol. 2006;5(1):53–8.
10. Shikora SA, Bergenstal R, Bessler M, et al. Implantable gastric stimulation for the treatment of clinically severe obesity: results of the SHAPE trial. Surg Obes Relat Dis. 2009;5(1):31–7.
11. Camilleri M, Toouli J, Herrera MF, et al. Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device. Surgery. 2008;143(6):723–31.
12. Stunkard A, Messick S. Eating inventory manual. San Antonio: Pearson; 1988. 37 p.
13. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA J Am Med Assoc. 2008;299(3):316–23.
14. Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142(7):547–59.
15. Shikora SA. Implantable gastric stimulation for the treatment of severe obesity. Obes Surg. 2004;14(4):545–8.
16. Myers JA, Clifford JC, Sarker S, et al. Quality of life after laparoscopic adjustable gastric banding using the Baros and Moorehead-Ardelt Quality of Life Questionnaire II. JSLS J Soc Laparoendosc Surg Soc Laparoendosc Surg. 2006;10(4):414–20.
17. Martinez Y, Ruiz-Lopez MD, Gimenez R, et al. Does bariatric surgery improve the patient's quality of life? Nutr Hosp. 2010;25(6):925–30.
18. Moorehead MK, Ardelt-Gattinger E, Lechner H, et al. The validation of the Moorehead-Ardelt Quality of Life Questionnaire II. Obes Surg. 2003;13(5):684–92.
19. Folope V, Hellot MF, Kuhn JM, et al. Weight loss and quality of life after bariatric surgery: a study of 200 patients after vertical gastroplasty or adjustable gastric banding. Eur J Clin Nutr. 2008;62(8):1022–30.
20. Chaput JP, Drapeau V, Hetherington M, et al. Psychobiological impact of a progressive weight loss program in obese men. Physiol Behav. 2005;86(1–2):224–32.
21. Bas M, Donmez S. Self-efficacy and restrained eating in relation to weight loss among overweight men and women in Turkey. Appetite. 2009;52(1):209–16.
22. Bohdjalian A, Prager G, Aviv R, et al. One-year experience with Tantalus: a new surgical approach to treat morbid obesity. Obes Surg. 2006;16(5):627–34.
23. Adami GF, Gandolfo P, Dapueto R, et al. Eating behavior following biliopancreatic diversion for obesity: study with a three-factor eating questionnaire. Int J Eat Disord. 1993;14(1):81–6.
24. Rucker D, Padwal R, Li SK, et al. Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ. 2007;335(7631):1194–9.
25. Stroh C, Hohmann U, Schramm H, et al. Fourteen-year long-term results after gastric banding. J Obes. 2011;2011:128451.
26. Ponce J, Lindsey B, Pritchett S, et al. New adjustable gastric bands available in the United States: a comparative study. Surg Obes Relat Dis. 2011;7(1):74–9.
27. Yao S, Ke M, Wang Z, et al. Visceral sensitivity to gastric stimulation and its correlation with alterations in gastric emptying and accommodation in humans. Obes Surg. 2005;15(2):247–53.
28. Aelen P, Jurkov A, Aulanier A, et al. Pilot acute study of feedback-controlled retrograde peristalsis invoked by neural gastric electrical stimulation. Physiol Meas. 2009;30(3):309–22.
29. Li Y, Yao S, Chen S, et al. The acute effects of a new type of implantable gastric electrical stimulators featuring varied pulse widths on beagle dogs' food intake and gastric accommodation. Obes Surg. 2014;24(5):783–90.
30. Gardiner PA, Eakin EG, Healy GN, et al. Feasibility of reducing older adults' sedentary time. Am J Prev Med. 2011;41(2):174–7.
31. Koizumi D, Rogers NL, Rogers ME, et al. Efficacy of an accelerometer-guided physical activity intervention in community-dwelling older women. J Phys Act Health. 2009;6(4):467–74.
32. Paschali AA, Goodrick GK, Kalantzi-Azizi A, et al. Accelerometer feedback to promote physical activity in adults with type 2 diabetes: a pilot study. Percept Mot Skills. 2005;100(1):61–8.
33. Catenacci VA, Wyatt HR. The role of physical activity in producing and maintaining weight loss. Nat Clin Pract Endocrinol Metab. 2007;3(7):518–29.
34. Kushner RF, Choi SW. Prevalence of unhealthy lifestyle patterns among overweight and obese adults. Obesity (Silver Spring). 2009;18(6):1160–7.
35. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot AJHP. 1997;12(1):38–48.